Author:
Biedroń Rafał,Ciszek Marta,Tokarczyk Marianna,Bobek Małgorzata,Kurnyta Maria,Słominska Ewa M.,Smoleński Ryszard T.,Marcinkiewicz Janusz
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology,Immunology and Allergy
Reference24 articles.
1. Adamiec M., Adamus J., Ciebiada I., Denys A. and Gebicki J. (2006): Search for drugs of the combined anti-inflammatory and anti-bacterial properties: 1-methyl-N′-(hydroxymethyl) nicotinamide. Pharmacol. Rep., 58, 246–249.
2. Bryniarski K., Biedron R., Jakubowski A., Chłopicki S. and Marcinkiewicz J. (2008): Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin. Eur. J. Pharmacol., 578, 332–338.
3. Chlopicki S., Swies J., Mogielnicki A., Buczko W., Bartus M., Lomnicka M., Adamus J. and Gebicki J. (2007): 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts antithrombotic activity mediated by COX-2/PGI2 pathway. Br. J. Pharmacol., 152, 230–239.
4. Creeke P. I. and Seal A. J. (2005): Quantitation of the niacin metabolites 1-methylnicotinamide and l-methyl-2-pyridone-5-carboxamide in random spot urine samples, by ion-pairing reverse-phase HPLC with UV detection, and the implications for the use of spot urine samples in the assessment of niacin status. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 817, 247–253.
5. Daniel J., Marechal Y., Van Gool F., Andris F. and Leo O. (2007): Nicotinamide inhibits B lymphocyte activation by disrupting MAPK signal transduction. Biochem. Pharmacol., 73, 831–842.
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献